By Helgi Library - May 25, 2023
Pilulka made a net profit of CZK -65.7 mil in 2022, down 156% compared to the previous year. Total sales reached CZK 2,465 mil, ...
By Helgi Library - May 25, 2023
Pilulka made a net profit of CZK -65.7 mil in 2022, down 156% compared to the previous year. Total sales reached CZK 2,465 mil, ...
By Helgi Library - May 25, 2023
Pilulka made a net profit of CZK -65.7 mil with revenues of CZK 2,465 mil in 2022, down by 156% and up by 2.16%, re...
| Profit Statement |
| Balance Sheet |
| Ratios |
| Valuation |
Get all company financials in excel:
Get all company financials in excel:
By Helgi Library - May 25, 2023
Pilulka made a net profit of CZK -65.7 mil with revenues of CZK 2,465 mil in 2022, down by 156% and up by 2.16%, respectively, compared to the previous year. This translates into a net margin of -2.66%. Historically, between 2018 - 2022, the firm...
By Helgi Library - May 25, 2023
Pilulka employed 383 employees in 2022, up 5.51% compared to the previous year. Historically, between 2018 and 2022, the firm's workforce hit a high of 383 employees in 2022 and a low of 217 employees in 2018. Average personnel cost stood at USD 2,57...
By Helgi Library - May 25, 2023
Pilulka employed 383 employees in 2022, up 5.51% compared to the previous year. Historically, between 2018 and 2022, the firm's workforce hit a high of 383 employees in 2022 and a low of 217 employees in 2018. Average personnel cost stood at USD 2,57...
By Helgi Library - May 25, 2023
Pilulka stock traded at CZK 650 per share at the end 2022 translating into a market capitalization of USD 74.7 mil. Since the end of 2017, stock has appreciated by 0% representing an annual average growth of %. In absolute terms, the value of the compan...
By Helgi Library - May 25, 2023
Pilulka stock traded at CZK 650 per share at the end 2022 translating into a market capitalization of USD 74.7 mil. Since the end of 2017, stock has appreciated by 0% representing an annual average growth of %. In absolute terms, the value of the compan...
By Helgi Library - May 25, 2023
Pilulka made a net profit of CZK -65.7 mil in 2022, down 156% compared to the previous year. Historically, between 2018 and 2022, the company's net profit reached a high of CZK -25.6 mil in 2020 and a low of CZK -65.7 mil in 2022. The result implies a ret...
By Helgi Library - May 25, 2023
Pilulka made a net profit of CZK -65.7 mil in 2022, down 156% compared to the previous year. Historically, between 2018 and 2022, the company's net profit reached a high of CZK -25.6 mil in 2020 and a low of CZK -65.7 mil in 2022. The result implies a ret...
By Helgi Library - May 25, 2023
Pilulka invested a total of CZK 69.3 mil in 2022, down 12.2% compared to the previous year. Historically, between 2018 - 2022, the company's investments stood at a high of CZK 78.9 mil in 2021 and a low of CZK 26.4 mil in 2020. As a p...
By Helgi Library - May 25, 2023
Pilulka invested a total of CZK 69.3 mil in 2022, down 12.2% compared to the previous year. Historically, between 2018 - 2022, the company's investments stood at a high of CZK 78.9 mil in 2021 and a low of CZK 26.4 mil in 2020. As a p...
By Helgi Library - May 25, 2023
Pilulka made a net profit of CZK -65.7 mil with revenues of CZK 2,465 mil in 2022, down by 156% and up by 2.16%, respectively, compared to the previous year. This translates into a net margin of -2.66%. Historically, between 2018 and 2022, the firmâ...
Pilulka has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of in 2050, or of sales. That’s compared to % average margin seen in last five years.
The company netted in 2050 implying ROE of and ROCE of . Again, the average figures were % and %, respectively when looking at the previous 5 years.
Pilulka’s net debt amounted to at the end of 2050, or of equity. When compared to EBITDA, net debt was x, up when compared to average of x seen in the last 5 years.
Pilulka stock traded at per share at the end of 2050 resulting in a market capitalization of . Over the previous five years, stock price grew by 0% or % a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of x and price to earnings (PE) of x as of 2050.
Helgi Library 
